Blockbuster Osteoporosis Drug Moves Towards FDA Approval
Denosumab, a ground-breaking osteoporosis drug that’s been moving through clinical trials for several years, is set to take the first step towards FDA approval this week. An advisory panel will meet Thursday to make recommendations as to whether denosumab, which will be marketed under the brand name Prolia, should be approved for... Read more








